Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
Xconomy
JANUARY 25, 2019
In a week of big personnel moves, none was more surprising than Editas Medicine CEO Katrine Bosley’s departure.
Xconomy
JANUARY 25, 2019
In a week of big personnel moves, none was more surprising than Editas Medicine CEO Katrine Bosley’s departure.
Xconomy
OCTOBER 7, 2016
PRICE FIGHTS. With some caveats, ICER recommended lower prices. —Merrimack Pharmaceuticals (NASDAQ: MACK ) announced layoffs of 22 percent of its staff and the resignation of CEO Robert Mulroy. . —The Nobel in Chemistry went to three scientists, in France, the Netherlands, and the U.S., CLINICAL NEWS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JULY 1, 2016
At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.
Xconomy
MAY 22, 2017
Bloomberg reported that the cuts were a response to lagging stock prices and CEO Mark Fields’s desire to trim company costs this. Read more » Reprints | Share:
Xconomy
JUNE 30, 2017
There is no Obamacare replacement, at least not as of this writing. The Senate Republicans are fractured, with a handful of conservatives and moderates each giving a cold shoulder to their chamber’s version of healthcare reform, the Better Care Reconciliation Act.
Xconomy
SEPTEMBER 15, 2017
It was a week of realignments. President Trump, who used to be known as “The Donald” but now goes by “ Amnesty Don ,” kept up the parlay-voo with his new friends Chuck and Nancy. Martin Shkreli, who was once known— and still is!
Xconomy
MARCH 3, 2017
In an address to Congress this week, President Donald Trump outlined many of his near-term goals, including an overhaul of the Affordable Care Act, also known as Obamacare, even as public opinion has begun to shift in favor of the law.
Let's personalize your content